Feasibility and Acceptability of Prolonged Exposure in Primary Care (PE-PC) for Posttraumatic Stress Disorder in Federally Qualified Health Centers: A Pilot Study.

Feasibility and Acceptability of Prolonged Exposure in Primary Care (PE-PC) for Posttraumatic Stress Disorder in Federally Qualified Health Centers: A Pilot Study.
复制标题

在联邦资格卫生中心的初级保健(PE-PC)长期暴露(PE-PC)的可行性和可接受性:一项试点研究。

DOI:
10.1007/s10488-022-01195-1
复制
发表时间:
2022-09
影响因子:
2.6
通讯作者:
Rauch, Sheila A. M.
Rauch, Sheila A. M.
中科院分区:
医学3区
文献类型:
--
作者:
Sripada, Rebecca K.;Walters, Heather M.;Ganoczy, Dara;Avallone, Kimberly M.;Cigrang, Jeffrey A.;Rauch, Sheila A. M.

文献摘要

参考文献

相似文献

Posttraumatic stress disorder (PTSD) is a debilitating psychiatric disorder that affects 6% of U.S. adults, yet is treated in only 30% of affected individuals and even fewer low-income individuals. One third of the nation’s low-income individuals are treated in Federally Qualified Health Centers (FQHCs). Most of these facilities lack capacity to provide their patients with first-line, evidence-based treatments for PTSD such as Prolonged Exposure (PE). To address this problem, PE has been adapted for use in a primary care setting and demonstrated efficacy in a brief model for military service members (PE in Primary Care: PE-PC). The effectiveness of this treatment in civilian, low-resource settings such as FQHCs is unknown. This pilot study tested the feasibility and acceptability of PE-PC in 30 Michigan FQHC patients. High rates of therapy participation suggest that the intervention was feasible and acceptable. Semi-structured interview data from 10 patients and 5 FQHC providers indicated that the intervention was helpful and filled a critical need for effective PTSD treatment in the FQHC setting. Interviews also elucidated barriers such as transportation, provider training, and time commitment for patients and providers. These findings set the stage for a full-scale randomized controlled trial to test the effectiveness of PE-PC on PTSD symptoms in this low-resource, high-need setting. Trial registry ClinicalTrials.gov Identifier: NCT03711266. October 18, 2018.
DOI: 10.1186/1748-5908-4-50
发表时间: 2009-08-07
期刊: Implementation science : IS
影响因子: --
作者:
Damschroder LJ;Aron DC;Keith RE;Kirsh SR;Alexander JA;Lowery JC
通讯作者: Lowery JC
DOI: 10.1007/s00127-016-1208-5
发表时间: 2016-08
影响因子: 4.4
作者:
Goldstein RB;Smith SM;Chou SP;Saha TD;Jung J;Zhang H;Pickering RP;Ruan WJ;Huang B;Grant BF
通讯作者: Grant BF
DOI: 10.1186/s13012-019-0853-y
发表时间: 2019-02-01
影响因子: 7.2
作者:
Gale, Randall C.;Wu, Justina;Midboe, Amanda M.
通讯作者: Midboe, Amanda M.
DOI: 10.1037/0022-006x.75.5.671
发表时间: 2007-10-01
影响因子: 5.9
作者:
Bonanno, George A.;Galea, Sandro;Vlahov, David
通讯作者: Vlahov, David
DOI: 10.1002/jts.22523
发表时间: 2020-06-07
影响因子: 3.3
作者:
Jain, Shaili;Ortigo, Kile;Cloitre, Marylene
通讯作者: Cloitre, Marylene